Navigation Links
The Link Between Oxidized Phospholipids And Coronary Artery Disease

According to a recent study published for the first time, researchers have made the first causal connection between concentrations of oxidized phospholipids and the risk of coronary artery disease (CAD).//

As levels were also closely related to those of Lp(a) lipoprotein, the researchers suggest that that the established ability of the latter to promote atherosclerosis may be partly mediated by the proinflammatory oxidized phospholipids that are bound to it.

Lp(a) lipoprotein is composed of apolipoprotein (apo) B-100, to which apo(a) is covalently bound.

Believing that oxidized phospholipids on lipoproteins containing apo B-100 may explain some of the atherogenic properties of Lp(a) lipoprotein, Sotirios Tsimikas (University of California, San Diego) examined whether oxidized phospholipid levels were related to CAD in 504 patients undergoing angiography. The oxidized phospholipid content per particle of apo B-100 - otherwise known as the oxidized phospholipid: apo B-100 ratio - was determined from oxidized low-density lipoprotein levels.

Researchers say that the ratio correlated strongly with Lp(a) lipoprotein levels, with both measures showing a strong and graded association with the presence and extent of CAD (p<0.001 in both cases). In patients aged 60 years or less, those in the highest quartiles for oxidized phospholipid: apo B-100 ratio (<0.294) were more likely than those in the lowest quartile (>0.047) to have CAD (41% vs 19%, odds ratio [OR]=3.12), and the same was true for Lp(a) lipoprotein levels (<39.7 vs >8.8 mg/dl, 61% vs 30%, OR=3.64, p<0.001 in both cases).

Results indicated that in all participants, the association of oxidized phospholipid: apo B-100 ratio with obstructive CAD was independent of all clinical and lipid measures, apart from Lp(a) lipoprotein. For individuals aged 60 years or under, the ratio remained an independent predictor of CAD.

In conclusion researcher s say that in settings of enhanced oxidative stress and elevated Lp(a) lipoprotein levels, a pro-inflammatory milieu may predominate that contributes to the clinical expression of cardiovascular disease.

According to another recent study researchers suggest that proteins and enzymes that remove or destroy oxidized phospholipids prevent atherosclerosis and that proteins and enzymes that produce or retain oxidized phospholipids promote atherosclerosis , hence they say that oxidized phospholipids can be also used as a diagnostic marker of CAD.


Related medicine news :

1. Link Between Infection And Heart Disease
2. Prescription Drug Use Varies Widely Between States
3. Wait Between Pregnancies
4. Link Between Migraines and Behavioral Disorders
5. Link Between Obesity and Behavior in Kids
6. Link Between Mothers Depression and Violence in Children
7. Link Between Alcohol and Decrease in Brain Size
8. Link Between Musculoskeletal Pain and Vitamin D Deficiency
9. Link Between Hyperglycemia & Hospital Mortality
10. Link Between Alcohol Consumption And Cardiovascular Disease
11. Understanding The Link Between Hormone Replacement and Respiratory Disease
Post Your Comments:

(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of ... recognition of their exemplary accomplishments in worksite health promotion. , The Wellness at Work ... Symposium at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses ...
(Date:6/24/2016)... ... 2016 , ... A recent article published June 14 on E ... goes on to state that individuals are now more comfortable seeking to undergo not ... as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians ...
(Date:6/24/2016)... Marne, Michigan (PRWEB) , ... June 24, 2016 , ... ... awareness about the dangers associated with chronic pain and the benefits of holistic treatments, ... for individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) ...
(Date:6/24/2016)... ... 24, 2016 , ... The Pulmonary Hypertension Association (PHA) learned ... receive two significant new grants to support its work to advance research and ... by recognizing patients, medical professionals and scientists for their work in fighting pulmonary ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: